Radioembolization: Technical Tips and Follow-Up Imaging

Transarterial radioembolization (TARE) is a minimally invasive treatment modality for hepatocellular carcinoma (HCC) that delivers targeted radiation via radioactive microspheres. The procedure entails selective catheterization of the hepatic artery, followed by infusion of yttrium-90-labeled microspheres directly into the arterial supply of the tumor. Several technical strategies are employed to optimize precise radiation delivery while minimizing exposure to surrounding healthy liver tissue. Post-procedure imaging is crucial for assessing therapeutic efficacy. Contrast-enhanced CT or MRI is routinely performed to evaluate tumor response, which may manifest as reductions in tumor size, decreased vascularity, or increased necrosis. It is important to recognize that radioembolization-induced changes in the liver parenchyma can mimic tumor recurrence, which may lead to unnecessary additional interventions if misinterpreted. Follow-up imaging also plays an essential role in identifying potential complications, including non-target radiation injury and disease progression. Overall, TARE has demonstrated promising outcomes in improving survival and quality of life for patients with HCC, establishing itself as a valuable option within the multidisciplinary management of liver cancer.